133 related articles for article (PubMed ID: 37732414)
1. Synthesis of novel furan-based chalcone derivatives as anti-tuberculosis agents:
Dhivya LS; Kumaradoss KM
Future Med Chem; 2023 Sep; 15(18):1687-1701. PubMed ID: 37732414
[No Abstract] [Full Text] [Related]
2. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and
Dhivya LS; Pradeepa BR; Sarvesh S
Future Med Chem; 2022 Jun; 14(12):851-866. PubMed ID: 35548879
[No Abstract] [Full Text] [Related]
4. Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3-Triazoles: A Computational Docking Techniques.
Sadineni K; Reddy Basireddy S; Rao Allaka T; Yatam S; Bhoomandla S; Muvvala V; Babu Haridasyam S
Chem Biodivers; 2024 May; 21(5):e202400389. PubMed ID: 38457745
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and anti-Tb evaluation of chalcone derivatives as novel inhibitors of InhA.
L S D; M K K; Thamilselvan G
J Biomol Struct Dyn; 2023; 41(24):15165-15176. PubMed ID: 37349907
[TBL] [Abstract][Full Text] [Related]
6. Thiazole-Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation.
Kasetti AB; Singhvi I; Nagasuri R; Bhandare RR; Shaik AB
Molecules; 2021 May; 26(10):. PubMed ID: 34064806
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 1,2,3-triazole incorporated indole-piperazines as potent antitubercular agents: Design, synthesis, in vitro biological evaluation, molecular docking and ADME studies.
Reddyrajula R; Etikyala U; Manga V; Kumar Dalimba U
Bioorg Med Chem; 2024 Jan; 98():117562. PubMed ID: 38184947
[TBL] [Abstract][Full Text] [Related]
8. Chalcones and flavonoids as anti-tuberculosis agents.
Lin YM; Zhou Y; Flavin MT; Zhou LM; Nie W; Chen FC
Bioorg Med Chem; 2002 Aug; 10(8):2795-802. PubMed ID: 12057669
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic correlation of structurally modified chalcone derivatives as promising leads to treat tuberculosis.
Sabarathinam S; Ganamurali N; Satheesh S; Dhanasekaran D; Raja A
Future Med Chem; 2023 Oct; 15(20):1903-1913. PubMed ID: 37877262
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents.
Atta A; Fahmy S; Rizk O; Sriram D; Mahran MA; Labouta IM
Bioorg Chem; 2018 Oct; 80():721-732. PubMed ID: 30077175
[TBL] [Abstract][Full Text] [Related]
11. Syntheses of lipophilic chalcones and their conformationally restricted analogues as antitubercular agents.
Ahmad I; Thakur JP; Chanda D; Saikia D; Khan F; Dixit S; Kumar A; Konwar R; Negi AS; Gupta A
Bioorg Med Chem Lett; 2013 Mar; 23(5):1322-5. PubMed ID: 23369537
[TBL] [Abstract][Full Text] [Related]
12. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
[TBL] [Abstract][Full Text] [Related]
13. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
14. Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis.
Ramesh D; Joji A; Vijayakumar BG; Sethumadhavan A; Mani M; Kannan T
Eur J Med Chem; 2020 Jul; 198():112358. PubMed ID: 32361610
[TBL] [Abstract][Full Text] [Related]
15. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological screening and in silico studies of new N-phenyl-4-(1,3-diaryl-1H-pyrazol-4-yl)thiazol-2-amine derivatives as potential antifungal and antitubercular agents.
Nandurkar Y; Bhoye MR; Maliwal D; Pissurlenkar RRS; Chavan A; Katade S; Mhaske PC
Eur J Med Chem; 2023 Oct; 258():115548. PubMed ID: 37307623
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents.
Tiwari AP; Sridhar B; Boshoff HI; Arora K; Gautham Shenoy G; Vandana KE; Varadaraj Bhat G
Mol Divers; 2020 Nov; 24(4):1265-1279. PubMed ID: 31506871
[TBL] [Abstract][Full Text] [Related]
18. Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
Patil PS; Kasare SL; Haval NB; Khedkar VM; Dixit PP; Rekha EM; Sriram D; Haval KP
Bioorg Med Chem Lett; 2020 Oct; 30(19):127434. PubMed ID: 32717369
[TBL] [Abstract][Full Text] [Related]
19. Antitubercular activity assessment of fluorinated chalcones, 2-aminopyridine-3-carbonitrile and 2-amino-4H-pyran-3-carbonitrile derivatives: In vitro, molecular docking and in-silico drug likeliness studies.
Lagu SB; Yejella RP; Nissankararao S; Bhandare RR; Golla VS; Subrahmanya Lokesh BV; Rahman MM; Shaik AB
PLoS One; 2022; 17(6):e0265068. PubMed ID: 35709194
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
Kumar G; Krishna VS; Sriram D; Jachak SM
Eur J Med Chem; 2018 Aug; 156():871-884. PubMed ID: 30056283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
